Halozyme Therapeutics in (halo 1 08/15/28)
13F holders, Q4 2024 (December 31)10holders +1
2new positions
2sold out
$1.07avg. 13F price*
At the end of Q4 2024, 10 institutions reported holding Halozyme Therapeutics in (halo 1 08/15/28) in their 13F filings, up 1 from Q3 2024. 2 opened new positions and 2 sold out. The largest holders were Absolute Investment Advisers, LLC ($13.0M), Angelo Gordon & Co., L.P. ($9.4M) and Ofi Invest Asset Management ($7.7M).
- Company
- Halozyme Therapeutics in (halo 1 08/15/28)
- CUSIP
- 40637HAF6
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $4.0M |
| Exits | 2 | $373K |
All 13F filers, Q3 2024 → Q4 2024: 10,547,000 shares bought and 70,419 shares sold, net +10,476,581 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Absolute Investment Advisers, LLC | 1.67% | Add +9.1% | 12,000,000 | $13.0M |
| Angelo Gordon & Co., L.P. | 2.39% | Add +133.3% | 8,750,000 | $9.4M |
| Ofi Invest Asset Management | 0.18% | — | 7,400,000 | $7.7M |
| New York State Common Retirement Fund | 0.00% | New | 3,247,000 | $3.5M |
| Sonora Investment Management Group, LLC | 0.19% | No change | 2,280,000 | $2.5M |
| Bank of New York Mellon Corp | 0.00% | Add +200.0% | 1,200,000 | $1.3M |
| Toronto Dominion Bank | 0.00% | New | 500,000 | $541K |
| Sei Investments Co. | 0.00% | No change | 322,000 | $347K |
| Oppenheimer Asset Management Inc. | 0.00% | Reduce -8.0% | 162,000 | $175K |
| Stephens Inc. | 0.00% | Reduce -47.4% | 50,000 | $54K |
"% of holder's portfolio" is HALOZYME THERAPEUTICS IN (HALO 1 08/15/28)'s weight in each manager's 13F, not the share of Halozyme Therapeutics in (halo 1 08/15/28) the manager owns.